hydroxychloroquine has been researched along with gx 15-070 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Addioui, A; Beaunoyer, M; Belounis, A; Cournoyer, S; Haddad, E; Le Gall, R; Nyalendo, C; Sartelet, H; Teira, P; Vassal, G | 1 |
1 other study(ies) available for hydroxychloroquine and gx 15-070
Article | Year |
---|---|
GX15-070 (Obatoclax), a Bcl-2 family proteins inhibitor engenders apoptosis and pro-survival autophagy and increases Chemosensitivity in neuroblastoma.
Topics: Adrenal Gland Neoplasms; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Hydroxychloroquine; Indoles; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neuroblastoma; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Tumor Burden; Xenograft Model Antitumor Assays | 2019 |